Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Positive Allosteric Modulator ofα2/3-Containing GABAAReceptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury
Jeffrey M. Witkin, Guanguan Li, Lalit K. Golani, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 372, Iss. 1, pp. 83-94
Open Access | Times Cited: 23

Showing 23 citing articles:

GABAkines – Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors
Rok Cerne, Arnold S. Lippa, Michael M. Poe, et al.
Pharmacology & Therapeutics (2021) Vol. 234, pp. 108035-108035
Open Access | Times Cited: 71
Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions
Victoria M. Golub, Doodipala Samba Reddy
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 387-438
Open Access | Times Cited: 58
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 40
Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy
Alexander Bryson, Christopher A. Reid, Steven Petrou
Journal of Neurochemistry (2023) Vol. 165, Iss. 1, pp. 6-28
Open Access | Times Cited: 24
Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)
Jeffrey M. Witkin, Hana Shafique, Rok Cerne, et al.
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108609-108609
Closed Access | Times Cited: 8
Neural circuit changes in neurological disorders: Evidence from in vivo two-photon imaging
Huan Xiong, Fei Tang, Yujie Guo, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101933-101933
Open Access | Times Cited: 13
Treatment options for post-traumatic epilepsy: An update on clinical and translational aspects
Marco Mula
Expert Review of Neurotherapeutics (2025)
Closed Access
Glutamate-Based Therapeutic Strategies for Schizophrenia: Emerging Approaches Beyond Dopamine
Mihaela Fadgyas Stănculete, Octavia Căpățînă
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4331-4331
Open Access
ENX‐101, a GABAA receptor α2,3,5‐selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models
Jordi Serrats, Krishna C. Vadodaria, William D. Brubaker, et al.
Epilepsia (2025)
Open Access
Clinical presentations of post ischemic and post traumatic brain injury scars associated seizures
Vishal Chavda, Vimal Patel, Parmar Harisinh Vajesinh, et al.
Neurological Research (2025), pp. 1-16
Closed Access
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
Cameron S. Metcalf, Jennifer Huff, Kyle Thomson, et al.
Epilepsia Open (2019) Vol. 4, Iss. 3, pp. 452-463
Open Access | Times Cited: 28
New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe Epilepsy
Dishary Sharmin, Branka Divović, Xingjie Ping, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 517-526
Closed Access | Times Cited: 2
Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation
Kamal Prakash Pandey, Branka Divović, Farjana Rashid, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 1, pp. 50-61
Open Access | Times Cited: 6
The α2,3-selective potentiators of GABAA receptors, KRM-II-81 and MP-III-80, produce anxiolytic-like effects and block chemotherapy-induced hyperalgesia in mice without tolerance development
Andrew Biggerstaff, Bronwyn M. Kivell, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 196, pp. 172996-172996
Open Access | Times Cited: 15
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects
Daniel E. Knutson, Jodi L. Smith, Xingjie Ping, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 17, pp. 2624-2637
Open Access | Times Cited: 15
BAER‐101, a selective potentiator of α2‐ and α3‐containing GABAA receptors, fully suppresses spontaneous cortical spike‐wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS)
Alexandra A. MacLean, Amy S. Chappell, Jay Kranzler, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 1
Nonsedating anxiolytics
Rok Cerne, Jodi L. Smith, Aleksandra Chrzanowska, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173895-173895
Closed Access | Times Cited: 1
Comparative anticonvulsant activity of the GABAkine KRM‐II‐81 and a deuterated analog
Xingjie Ping, Michelle Meyer, Nicolas M. Zahn, et al.
Drug Development Research (2023) Vol. 84, Iss. 3, pp. 601-605
Open Access | Times Cited: 3
KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy
Jodi L. Smith, Jeremy Wertz, Arnold S. Lippa, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23752-e23752
Open Access | Times Cited: 3
Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3‐selective GABAkine KRM‐II‐81
Lalit K. Golani, Branka Divović, Dishary Sharmin, et al.
Biopharmaceutics & Drug Disposition (2022) Vol. 43, Iss. 2, pp. 66-75
Closed Access | Times Cited: 5
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands
Kamal Prakash Pandey, Md Zubair Ahmed Khan, Lalit K. Golani, et al.
ARKIVOC (2020) Vol. 2020, Iss. 7, pp. 242-256
Open Access | Times Cited: 6
Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
Chih‐Sheng Yang, Man-Chun Wu, Ming‐Chi Lai, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13143-13143
Open Access | Times Cited: 1
8-Substituted Triazolobenzodiazepines: In Vitro and In Vivo Pharmacology in Relation to Structural Docking at the α1 Subunit-Containing GABAA Receptor
Lalit K. Golani, Donna M. Platt, Daniela Rüedi‐Bettschen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 3
New and Emerging Antiepileptic Drugs
Jeffrey M. Witkin, Lalit K. Golani, Jodi L. Smith
Burger's Medicinal Chemistry and Drug Discovery (2021), pp. 1-30
Closed Access | Times Cited: 2
Page 1

Scroll to top